Artículos relacionados a The Science of Glaucoma Management: From Translational...

The Science of Glaucoma Management: From Translational Research to Next-Generation Clinical Practice - Tapa blanda

 
9780323884426: The Science of Glaucoma Management: From Translational Research to Next-Generation Clinical Practice
Tapa blanda
ISBN 10: 0323884423 ISBN 13: 9780323884426
Editorial: Academic Press, 2023

Sinopsis

The Science of Glaucoma Management: From Translational Research to Next-Generation Clinical Practice bridges the gap between laboratory research and clinicians by bringing the latest promising research directly from researchers to clinicians long before they translate into clinical advances, and often before they are presented at conferences. Organized as a series of clinically relevant topics written by world-leading experts, this book summarizes the current state of laboratory and translational research and draws on the potential implications for day-to-day clinical practice. It offers new insights and mind-opening statements through contributions from some of the most respected glaucoma research groups. The book allows glaucoma specialists to explore novel ways to refine and rethink their practice based on the latest discoveries in basic sciences and breakthrough technologies, and to gain a better understanding on how their specialty is evolving and how research may shape tomorrow’s practice.

"Sinopsis" puede pertenecer a otra edición de este libro.

Acerca de los autores

Dr Kevin Gillmann is an ophthalmologist, glaucoma specialist and researcher. He shares his clinical work between Geneva and London, where he is an honorary fellow of Moorfields Eye Hospital. He graduated from Newcastle University Medical School in 2013 (MBBS) and became a Fellow of the European Board of Ophthalmologists in 2018. In 2019, he completed his residency within Professor André Mermoud's glaucoma unit and graduated a Medical Doctorate (MD) on Minimally-Invasive Glaucoma Surgery (MIGS) from the University of Lausanne.

His research with Stanford University and the Swiss Glaucoma Research Foundation focuses primarily on minimally invasive glaucoma surgery, neuroprotection and personalised glaucoma therapies. His work was featured on the frontpage of several magazines and in high-impact journals such as Nature's Eye and the British Journal of Ophthalmology, and received grants from the BrightFocus Foundation. With over 50 peer-reviewed articles, contributions to several book chapters and international guidelines, he was recently ranked amongst the top 0.5% glaucoma experts worldwide by ExpertScape.

Dr Gillmann frequently gives lectures both nationally and internationally, including at the University of Liverpool and the University of London, where he was awarded a prize for academic achievements. Aside from his activities as a clinicians and educator, Dr Gillmann has also devoted some of his research to the study and improvement of patient experience in healthcare services. He was awarded a postgraduate certificate in Media and Medicine from Harvard Medical School, a Master of Business Administration (MBA) with distinctions from the University of London, and a Master of Architecture from the University of Paris LaVillette where he wrote a thesis on the interconnections between hospital design, patient perception and society.

Prof. Mansouri is currently a consultant ophthalmologist at Montchoisi Clinic, Lausanne, Switzerland; and an Adjoint Professor at the Department of Ophthalmology in University of Colorado School of Medicine, Denver, USA. He pioneered the use of 24-hour IOP-monitoring technology for patients with glaucoma by contributing to the development of the IOP-sensing contact lens, Triggerfish, and was the first ophthalmologist to give a TEDx talk. A MIGS pioneer, Kaweh leads many instructional courses at international meetings and has over 75 peer-reviewed publications, including several high-profile publications and journal covers. He has contributed to a number of glaucoma textbooks, including the World Glaucoma Association Consensus Series. Prof. Mansouri is also President of the Swiss Glaucoma Research Foundation, Executive Vice President of the World Glaucoma Association, and Glaucoma Editor of the Asia-Pacific Journal of Ophthalmology.

De la contraportada

Glaucoma is a neurodegenerative disease in which premature death of retinal ganglion cells lead to progressive visual loss. Despite being the leading unpreventable cause of blindness worldwide, the pathophysiology of glaucoma is still poorly understood. International research has been extremely active in recent years in the field of glaucoma, and significant advances are made monthly in most aspects of glaucoma research. Yet, it often takes years, if not decades, for laboratory findings to translate into clinical practice and benefit patients.

The Science of Glaucoma Management aims to bridge the gap between laboratory research and clinicians. Organized as a series of clinically relevant topics written by world-leading experts of their fields, this book summarizes the current state of laboratory and translational research and draws on the potential implications for day-to-day clinical practice. It offers new insights and mind-opening statements through contributions from some of the most respected glaucoma research groups. It allows glaucoma specialists to explore novel ways to refine and rethink their practice based on the latest discoveries in basic sciences and breakthrough technologies, and to understand how their specialty is evolving and how research may shape tomorrow’s practice.

"Sobre este título" puede pertenecer a otra edición de este libro.

Editorial
Academic Press
Año de publicación
2023
Idioma
Inglés
ISBN 10 
0323884423
ISBN 13 
9780323884426
Encuadernación
Tapa blanda
Número de páginas
482
Editor
Gillmann
Contacto del fabricante
Academic Press
https://shop.elsevier.com/

230 PARK AVENUE, SUITE 800
NY
NY
10169
Estados Unidos de America
Persona responsable
Barbara Criscuolo
b.criscuolo@lswr.it

Via Spadolini, 7
Milano
20141
Italia